List of directors and their roles and functions

Resignation of Non-Executive Director

List of Directors and their Roles and Functions

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

1st Patient Enrolled in Phase 3 Study of Boan’s Nivolumab

Boan Biotech (6955.HK) announced today that the first patient in Phase III clinical trial of its Nivolumab Injection (BA1104) in China has been enrolled. BA1104 is the first biosimilar to Opdivo® to u...

Voluntary Announcement First Patient Enrolled in Phase III Clinical Trial of Nivolumab Injection (BA1104) in China

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

The Results of a Phase I Clinical Trial Comparing Boan Biotech’s BA1102 with XGEVA® Published in Journal of Bone Oncology

Yantai, September 27, 2023 - The results of a Phase I clinical trial comparing BA1102, a biosimilar candidate developed by Boan Biotech, with the reference drug denosumab (XGEVA®), were recently publi...

2023 Interim Report